BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 35955873)

  • 1. Mechanisms of Systemic Osteoporosis in Rheumatoid Arthritis.
    Pietschmann P; Butylina M; Kerschan-Schindl K; Sipos W
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheumatoid arthritis and bone -periarticular and systemic bone loss-].
    Ono K; Ohashi S; Tanaka S
    Clin Calcium; 2013 Feb; 23(2):249-55. PubMed ID: 23354093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of bone destruction in rheumatoid arthritis and perspectives of the treatment].
    Koyama T; Tanaka S
    Clin Calcium; 2016 May; 26(5):735-41. PubMed ID: 27117620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical immunity in bone and joints.
    Tanaka Y
    J Bone Miner Metab; 2019 Jan; 37(1):2-8. PubMed ID: 30324535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone structure in rheumatoid arthritis].
    Ono K; Ohashi S; Tanaka S; Matsumoto T
    Clin Calcium; 2013 Jul; 23(7):983-91. PubMed ID: 23811586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
    Kaur S; White S; Bartold M
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic intervention of rheumatoid arthritis bone loss].
    Ono K; Ohashi S; Tanaka S
    Clin Calcium; 2013 Sep; 23(9):1345-52. PubMed ID: 23999372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review.
    Fardellone P; Salawati E; Le Monnier L; Goëb V
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33092162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis in rheumatoid arthritis and ankylosing spondylitis.
    Vosse D; de Vlam K
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S62-7. PubMed ID: 19822048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches.
    Gupta N; Kanwar N; Arora A; Khatri K; Kanwal A
    Clin Rheumatol; 2024 May; 43(5):1421-1433. PubMed ID: 38499817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary osteoporosis. Bone metabolic disorder in Rheumatoid arthritis.].
    Nakano K; Okada Y; Tanaka Y
    Clin Calcium; 2018; 28(12):1599-1603. PubMed ID: 30487323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoimmunology: The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis.
    Yang M; Zhu L
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis.
    Tomizawa T; Ito H; Murata K; Hashimoto M; Tanaka M; Murakami K; Nishitani K; Azukizawa M; Okahata A; Doi K; Saito M; Furu M; Hamaguchi M; Mimori T; Matsuda S
    Arthritis Res Ther; 2019 Jul; 21(1):174. PubMed ID: 31307521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Anti-bone resorbing treatment for rheumatoid arthritis.].
    Tanaka Y
    Clin Calcium; 2018; 28(5):630-636. PubMed ID: 29731457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic therapies and systemic bone loss in rheumatoid arthritis.
    Dimitroulas T; Nikas SN; Trontzas P; Kitas GD
    Autoimmun Rev; 2013 Aug; 12(10):958-66. PubMed ID: 23542506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine-mediated bone destruction in rheumatoid arthritis.
    Jung SM; Kim KW; Yang CW; Park SH; Ju JH
    J Immunol Res; 2014; 2014():263625. PubMed ID: 25295284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments.
    Maeda K; Yoshida K; Nishizawa T; Otani K; Yamashita Y; Okabe H; Hadano Y; Kayama T; Kurosaka D; Saito M
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Conventional and Biological Disease Modifying Antirheumatic Drugs on Bone Biology. Rheumatoid Arthritis as a Case Study.
    Barreira SC; Fonseca JE
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):100-9. PubMed ID: 27166684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of osteoporosis in rheumatoid arthritis patients.
    Hoes JN; Bultink IE; Lems WF
    Expert Opin Pharmacother; 2015 Mar; 16(4):559-71. PubMed ID: 25626121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune molecules and the mechanism of joint destruction].
    Komatsu N
    Clin Calcium; 2016 May; 26(5):683-9. PubMed ID: 27117613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.